MedStar Authors catalog › Details for: Review: Stent fracture in the drug-eluting stent era. [Review]
Normal view MARC view ISBD view

Review: Stent fracture in the drug-eluting stent era. [Review]

by Omar, Al Fazir; Pendyala, Lakshmana K; Waksman, Ron.
Citation: Cardiovascular Revascularization Medicine. 17(6):404-11, 2016 Sep.Journal: Cardiovascular revascularization medicine : including molecular interventions.Published: 2016ISSN: 1878-0938.Full author list: Omar A; Pendyala LK; Ormiston JA; Waksman R.UI/PMID: 27499060.Subject(s): *Cardiovascular Agents/ad [Administration & Dosage] | Coronary Restenosis/et [Etiology] | Coronary Thrombosis/et [Etiology] | *Drug-Eluting Stents | Humans | *Percutaneous Coronary Intervention/ae [Adverse Effects] | *Percutaneous Coronary Intervention/is [Instrumentation] | Prosthesis Design | *Prosthesis Failure | Risk Factors | Treatment OutcomeInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal Article | ReviewDigital Object Identifier: (Click here) Abbreviated citation: Cardiovasc Revasc Med. 17(6):404-11, 2016 Sep.Local Holdings: Available in print through MWHC library: 2002 - present.Abstract: Stent fracture has been recognized as one cause of stent failure and has been associated with in-stent restenosis and stent thrombosis, even in 2nd-generation drug-eluting stents. Given the wide use of drug-eluting stents and paucity of contemporary data available concerning stent fracture, we reviewed clinical studies and the Food and Drug Administration's Manufacturer and User Device Experience (MAUDE) database to analyze the current trends, mechanisms, predictors, outcomes and treatment for stent fracture. Abstract: Copyright © 2016 Elsevier Inc. All rights reserved.

Powered by Koha